Hospital-at-home programs hit speed bumps
Health systems cite high costs, regulatory uncertainty and a dearth of eligible patients for scrapping or pausing hospital-at-home program expansions.
Health systems cite high costs, regulatory uncertainty and a dearth of eligible patients for scrapping or pausing hospital-at-home program expansions.
One-third of outpatient commercial claims go unpaid at 90 days. The physician’s role in improving private practices’ revenue-cycle management is key.
Even the most savvy patients with diabetes can err in adjusting insulin pumps for US seasonal time shifts, adding to the evidence supporting ending these…
This randomized clinical trial of social housing building residents in Ontario, Canada, evaluates the effects of a community paramedicine program vs usual care on health…
A fierce rivalry is brewing between gene-editing companies Prime Medicine and Tessera Therapeutics. Jeremy Duffield, Prime’s chief scientific officer, implied publicly that Tessera’s approach is…
AbbVie will buy Aliada Therapeutics for $1.4 billion in cash, it said on Monday, gaining access to the privately held therapy developer’s Alzheimer’s disease candidate…
West Berkshire Councillors warn flooding “will be as bad as last year, possibly worse”.
This week at HLTH, FDA Commissioner Robert Califf discussed the current state of healthcare AI. He talked about some of the qualms he has, such…
Novartis is getting global rights to a Monte Rosa Therapeutic molecular glue degrader drug in early clinical testing as a potential treatment for autoimmune disorders.…
As cannabis is legalized and is more accessible in various forms across the country, there is increasing concern among health care providers about potential impact…
The California Department of Public Health is dedicated to optimizing the health and well-being of Californians